The Deals You're Not Allowed to Read
Watch how this administration operates and one habit surfaces again and again: the terms that matter are the ones you are not permitted to see. A deal is announced with fanfare, its benefit to the public asserted, and the actual text locked away. When the paperwork does surface, it turns out to have been written for capital. The clearest case is unfolding right now in drug pricing.
The Washington Post has revealed the secret contracts behind Trump's drug-pricing deals, and the undisclosed terms tell you who the deals were for. The agreements with Pfizer and Eli Lilly include tariff protections, overseas pricing inducements and broad confidentiality clauses. Read that list slowly. Tariff protection is a shield for the manufacturer. An overseas pricing inducement is a lever the manufacturer gets to pull in its own interest. And the confidentiality clause is the tell: an arrangement marketed to the public as relief on the price of medicine, whose real provisions the public is contractually forbidden from reading.
This is not incompetence. It is a method of government. The state sits down with Pfizer and Eli Lilly, hands them protections and inducements, then wraps the whole thing in secrecy so the beneficiaries — the people who actually swallow the pills — cannot check the terms against the promise. When the party paying for a product is barred from seeing the contract, the contract was never written for them.
The same instinct decides who is allowed to watch at all. This administration has barred CNN, MS NOW and Politico from the White House — a move to shrink the number of people who can report what power is doing. What the drug contract does with a confidentiality clause, the press office does with an access list. It is the same principle across the operation.
Set that against what people say they need. Fresh polling shows voters remain focused on inflation, jobs and the cost of living — the ordinary arithmetic of rent, groceries and prescriptions. The administration's answer is not to lower those costs but to change the subject: the president has responded by touting a list of 25 top achievements. A list is cheap. It is what you produce when material conditions have not improved and you need something to point at instead.
The structure repeats abroad. MSNBC argues that Trump's foreign policy recklessness is coming home to roost, because the president's actions overseas eventually have an effect here at home. Same shape: decisions taken at the top, consequences absorbed at the bottom. Even a move sold as strength runs through the same one-way channel — Zelenskyy publicly thanked Trump for signing a bill allowing the expansion of sanctions on Russia, a headline win announced upward while the costs of the wider posture settle downward and out of view.
Pull the thread and the argument holds: power here works by controlling what can be seen and contested. It negotiates privately with corporations, secures their protections in writing, forbids scrutiny of the writing, and manages the public with a narrative timed to the moment people are asking about their bills. It reaches for the same tool with human beings — a federal appeals court has just had to order the administration to give detainees a meaningful opportunity to contest deportation to countries where they have no ties, because the default was to deny them any chance to challenge what was being done to them.
The cost falls where it always falls. On the patient told medicine will get cheaper and not allowed to see the deal that supposedly guarantees it. On the worker naming inflation and rent as the problem and handed a press release in reply. On the detainee removed before a court could hear an objection. When a government's most important commitments are the ones it will not let you read, the people it answers to are not the ones who elected it — they are the ones on the other side of the signature.